Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.648 EUR | +1.10% | -1.90% | -38.05% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Sales 2024 * | 4.2M 4.52M | Sales 2025 * | 5.75M 6.19M | Capitalization | 20.24M 21.78M |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.53M | Net income 2025 * | 22M 23.67M | EV / Sales 2024 * | 10.2 x |
Net Debt 2024 * | 22.7M 24.43M | Net cash position 2025 * | 3.2M 3.44M | EV / Sales 2025 * | 2.96 x |
P/E ratio 2024 * |
-2.58
x | P/E ratio 2025 * |
0.8
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.22% |
1 day | +1.10% | ||
1 week | -1.90% | ||
Current month | +2.36% | ||
1 month | -34.47% | ||
3 months | -5.29% | ||
6 months | -15.49% | ||
Current year | -38.05% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.648 | +1.10% | 9,220 |
24-05-02 | 1.63 | +1.24% | 40,220 |
24-04-30 | 1.61 | -1.23% | 24,281 |
24-04-29 | 1.63 | -2.98% | 14,144 |
24-04-26 | 1.68 | -1.75% | 18,888 |
Real-time Euronext Paris, May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.05% | 21.81M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- ALDVI Stock